IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis

Journal of Infectious Diseases

Volumn 204, Issue 7, 2011, Pages 1134-1137

  Gautam, Shalini ^a   Kumar, Rajiv ^a   Maurya, Radheshyam ^a,b   Nylén, Susanne ^c,d   Ansari, Nasim ^d   Rai, Madhukar ^a   Sundar, Shyam ^a   Sacks, David ^d  

^a BANARAS HINDU UNIVERSITY   (India)

^b UNIVERSITY OF HYDERABAD   (India)

^c KAROLINSKA INSTITUTE   (Sweden)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AMASTIGOTE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEISHMANIA DONOVANI; MAJOR CLINICAL STUDY; MALE; PARASITE CLEARANCE; PARASITE SURVIVAL; PRIORITY JOURNAL; SPLEEN CELL; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; CELLS, CULTURED; CHILD; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MACROPHAGES; MALE; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 80052422191     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir461     Document Type: Article

References (15)

1. Couper K.N., Blount D.G., Riley E.M. IL-10: The master regulator of immunity to infection. J Immunol 2008; 180:5771-5777
2. Sabat R., Grutz G., Warszawska K., et al. Biology of interleukin-10. Cytokine Growth Factor Rev 2010; 21:331-344
3. Jangpatarapongsa K., Chootong P., Sattabongkot J., et al. Plasmodium vivax parasites alter the balance of myeloid and plasmacytoid dendritic cells and the induction of regulatory T cells. Eur J Immunol 2008; 38:2697-2705
4. Walther M., Woodruff J., Edele F., et al. Innate immune responses to human malaria: Heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes. J Immunol 2006; 177:5736-5745 (Pubitemid 44527649)
5. Almeida A.S., Lago P.M., Boechat N., et al. Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity. J Immunol 2009; 183:718-731
6. Boussiotis V.A., Tsai E.Y., Yunis E.J., et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000; 105:1317-1325 (Pubitemid 30266085)
7. Brockman M.A., Kwon D.S., Tighe D.P., et al. IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 2009; 114:346-356
8. Nylen S., Sacks D. Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol 2007; 28:378-384 (Pubitemid 47385375)
9. Carvalho E.M., Bacellar O., Brownell C., Regis T., Coffman R.L., Reed S.G. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. J Immunol 1994; 152:5949-5956
10. Ghalib H.W., Piuvezam M.R., Skeiky Y.A., et al. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 1993; 92:324-329 (Pubitemid 23209013)
11. Sacks D., Melby P. Animals models for the analysis of immune responses to leishmaniasis. In: Coico R ed. Current protocols in immunology. Vol 4. New York: John Wiley & Sons, 1998.
12. Nylen S., Maurya R., Eidsmo L., Manandhar K.D., Sundar S., Sacks D. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leish-maniasis. J Exp Med 2007; 204:805-817 (Pubitemid 46631610)
13. Olliaro P.L., Guerin P.J., Gerstl S., Haaskjold A.A., Rottingen J.A., Sundar S. Treatment options for visceral leishmaniasis: A systematic review of clinical studies done in India, 1980-2004. Lancet Infect Dis 2005; 5:763-774 (Pubitemid 41688981)
14. Murray H.W., Brooks E.B., DeVecchio J.L., Heinzel F.P. Immunoenhancement combined with amphotericin B as treatment for experimental visceral leishmaniasis. Antimicrob Agents Chemother 2003; 47:2513-2517 (Pubitemid 36919453)
15. Murray H.W., Flanders K.C., Donaldson D.D., et al. Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis. Infect Immun 2005; 73:3903-3911 (Pubitemid 40923128)